Andy Chen's Stock Ratings

Wolfe Research Analyst

Andy Chen is an analyst at Wolfe Research. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 11/23/2024

Overall Average Return

-4.03%

Smart Score

42.5%

Overall Average Return Percentile

28th

Number of Ratings

29
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
This Airbnb Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
The Latest Analyst Ratings For Kymera Therapeutics
Analyst Expectations For Celldex Therapeutics's Future
Co. Says Geoprobe Drilling Found 'Consistent' Lithium, Boron Concentrations
Source: Streetwise Reports 10/15/2024
The Analyst Landscape: 7 Takes On Kymera Therapeutics
This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
A Closer Look at 10 Analyst Recommendations For Celldex Therapeutics
Cracking The Code: Understanding Analyst Reviews For Kymera Therapeutics
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved